New Delhi, Apr 29 (PTI) Dr Reddy's Laboratories on Thursday said it has launched generic Albendazole tablets, used in the treatment of a variety of parasitic worm infestations, in the US market.

The Hyderabad-based drug major said it has launched the product, a generic version of GlaxoSmithKline's Albenza tablets (200 mg) after receiving approval from the US Food and Drug Administration (USFDA).

As per IQVIA Health data, the Albenza brand and generics had sales of around USD 27 million in the US for the most recent twelve months ending in November 2020.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)